201 related articles for article (PubMed ID: 25277774)
1. Highly effective inhibition of lung cancer growth and metastasis by systemic delivery of siRNA via multimodal mesoporous silica-based nanocarrier.
Chen Y; Gu H; Zhang DS; Li F; Liu T; Xia W
Biomaterials; 2014 Dec; 35(38):10058-69. PubMed ID: 25277774
[TBL] [Abstract][Full Text] [Related]
2. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
[TBL] [Abstract][Full Text] [Related]
3. Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy.
Chen Y; Wang X; Liu T; Zhang DS; Wang Y; Gu H; Di W
Int J Nanomedicine; 2015; 10():2579-94. PubMed ID: 25848273
[TBL] [Abstract][Full Text] [Related]
4. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-enabled, image-guided treatment planning of target specific RNAi therapeutics in an orthotopic prostate cancer model.
Lin Q; Jin CS; Huang H; Ding L; Zhang Z; Chen J; Zheng G
Small; 2014 Aug; 10(15):3072-82. PubMed ID: 24706435
[TBL] [Abstract][Full Text] [Related]
6. Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery.
Lin D; Jiang Q; Cheng Q; Huang Y; Huang P; Han S; Guo S; Liang Z; Dong A
Acta Biomater; 2013 Aug; 9(8):7746-57. PubMed ID: 23624221
[TBL] [Abstract][Full Text] [Related]
7. Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis.
Morry J; Ngamcherdtrakul W; Gu S; Goodyear SM; Castro DJ; Reda MM; Sangvanich T; Yantasee W
Biomaterials; 2015 Oct; 66():41-52. PubMed ID: 26196532
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional polyamidoamine-modified selenium nanoparticles dual-delivering siRNA and cisplatin to A549/DDP cells for reversal multidrug resistance.
Zheng W; Cao C; Liu Y; Yu Q; Zheng C; Sun D; Ren X; Liu J
Acta Biomater; 2015 Jan; 11():368-80. PubMed ID: 25204523
[TBL] [Abstract][Full Text] [Related]
9. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
[TBL] [Abstract][Full Text] [Related]
10. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
11. Systemic delivery of sticky siRNAs targeting the cell cycle for lung tumor metastasis inhibition.
Bonnet ME; Gossart JB; Benoit E; Messmer M; Zounib O; Moreau V; Behr JP; Lenne-Samuel N; Kedinger V; Meulle A; Erbacher P; Bolcato-Bellemin AL
J Control Release; 2013 Sep; 170(2):183-90. PubMed ID: 23727288
[TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles.
Feng Q; Yu MZ; Wang JC; Hou WJ; Gao LY; Ma XF; Pei XW; Niu YJ; Liu XY; Qiu C; Pang WH; Du LL; Zhang Q
Biomaterials; 2014 Jun; 35(18):5028-38. PubMed ID: 24680191
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable nano-polymeric system for efficient Akt1 siRNA delivery.
Jere D; Arote R; Jiang HL; Kim YK; Cho MH; Cho CS
J Nanosci Nanotechnol; 2010 May; 10(5):3366-9. PubMed ID: 20358958
[TBL] [Abstract][Full Text] [Related]
14. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
Han L; Tang C; Yin C
Biomaterials; 2014 May; 35(15):4589-600. PubMed ID: 24613049
[TBL] [Abstract][Full Text] [Related]
15. Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery.
Yang XZ; Du JZ; Dou S; Mao CQ; Long HY; Wang J
ACS Nano; 2012 Jan; 6(1):771-81. PubMed ID: 22136582
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional fluorescent-magnetic polyethyleneimine functionalized Fe3O4-mesoporous silica yolk-shell nanocapsules for siRNA delivery.
Zhang L; Wang T; Li L; Wang C; Su Z; Li J
Chem Commun (Camb); 2012 Sep; 48(69):8706-8. PubMed ID: 22824833
[TBL] [Abstract][Full Text] [Related]
17. Enhancing endosomal escape for nanoparticle mediated siRNA delivery.
Ma D
Nanoscale; 2014 Jun; 6(12):6415-25. PubMed ID: 24837409
[TBL] [Abstract][Full Text] [Related]
18. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
19. Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality.
Huang P; Chen Y; Lin H; Yu L; Zhang L; Wang L; Zhu Y; Shi J
Biomaterials; 2017 May; 125():23-37. PubMed ID: 28226244
[TBL] [Abstract][Full Text] [Related]
20. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
